Differential Expression ofCCN1/CYR61,CCN3/NOV,CCN4/WISP1, andCCN5/WISP2in Neurofibromatosis Type 1 Tumorigenesis
Authors:
- Eric PasmantEPEric Pasmant
- Nicolas OrtonneNONicolas Ortonne
- Laure RittièLRLaure Rittiè
- Bernard PerbalBPBernard Perbal
Open Access
- 1 January 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Neuropathology & Experimental Neurology
- Vol. 69 (1) , 60-69
Abstract
The hallmark of neurofibromatosis type 1 is the development of dermal and plexiform neurofibromas. Neurofibromatosis type 1 patients with plexiform nKeywords
This publication has 35 references indexed in Scilit:
- Large-Scale Molecular Comparison of Human Schwann Cells to Malignant Peripheral Nerve Sheath Tumor Cell Lines and TissuesCancer Research, 2006
- Subclassification of Nerve Sheath Tumors by Gene Expression ProfilingBrain Pathology, 2004
- Molecular Profiles of Neurofibromatosis Type 1-Associated Plexiform NeurofibromasClinical Cancer Research, 2004
- Neurofibromas in NF1: Schwann Cell Origin and Role of Tumor EnvironmentScience, 2002
- Expression of Leptin (Ob) and Leptin Receptor (Ob-R) in Human Fibroblasts: Regulation of Leptin Secretion by InsulinThe Journal of Clinical Endocrinology & Metabolism, 2001
- Epidemiology of neurofibromatosis type 1American Journal of Medical Genetics, 1999
- In vitro and in vivo behaviour of NDF‐expanded monkey Schwann cellsEuropean Journal of Neuroscience, 1998
- Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosisCell, 1992
- Type 1 Neurofibromatosis Gene: Identification of a Large Transcript Disrupted in Three NF1 PatientsScience, 1990
- A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutationsCell, 1990